Large surface cardiac ablation catherter that assumes a low profile during introduction into the heart

Abstract
A cardiac ablation catheter has an energy emitting surface for thermally destroying tissue. The surface normally presents a compact, low profile for introduction into the heart. Once introduced, the energy emitting surface can be significantly enlarged. The enlarged surface emits ablation energy sufficient to create a lesion that is significantly larger in terms of volume and geometry than the surface's initial low profile would provide.
Description




FIELD OF THE INVENTION




The invention relates to systems and methods for ablating the interior regions of the heart for treating cardiac conditions.




BACKGROUND OF THE INVENTION




It is believed that lesions larger than those created by current electrophysiological therapy are needed to more consistently cure myocardial ventricular tachycardia (MVT) of ischemic origins.




Conventional cardiac ablation systems designed to cure re-entrant supra ventricular tachycardia (SVT), often create lesions in myocardial tissue with a penetration depth of about 3 to 5 mm and a lesion volume of less than 0.2 cm


3


, depending upon the size of the electrode and the amount of power that is applied.




However, to consistently cure MVT by ablation, a penetration depth greater than 3 to 5 mm and a lesion volume of at least 1 cm


3


is estimated to be required.




The solution lies in larger electrodes. Yet, larger electrodes themselves pose problems of size and maneuverability that weigh against safe and easy introduction through a vein or artery into the heart.




A need exists for cardiac ablation catheters having that flexibility and maneuverability that permits safe and easy introduction into the heart and, once deployed inside the heart, emit energy sufficient to cause permanent, irreversible thermal damage to large regions of myocardial tissue.




SUMMARY OF THE INVENTION




The invention provides a cardiac ablation catheter having an energy emitting surface for thermally destroying tissue. The surface normally presents a compact, low profile for introduction into the heart.




Once introduced, the energy emitting surface can be significantly enlarged. The enlarged surface emits ablation energy sufficient to create a lesion that is significantly larger in terms of volume and geometry than the surface's initial low profile would provide.




The catheter of this invention is configured to produce lesions with a greater surface area, compared to standard cardiac ablation catheters, while maintaining a standard (6, 7, or 8 French) introducer size (a “French” equals 0.013 inches).




The enlarged surface area creates larger lesions, since the lesion volume and geometry are factors which are controlled according to the shape and size of the energy emitting surface.




In accordance with a further aspect of the invention, an inflatable surface is produced using a thermoplastic polymeric material such as polyethylene. The inflatable surface is coated, all or partially, with an energy emitting material. When deflated, such a surface presents a compact profile. When inflated, the same surface has an significantly enlarged dimension of, for example, approximately 7 to 12 mm.




Another aspect of the invention is an expandable energy emitting surface with an associated temperature sensor.




In an alternative arrangement, the expandable surface can also be used for obtaining electrogram recordings or for similar mapping procedures.




The invention may be embodied in several forms without departing from its spirit or essential characteristics. The scope of the invention is defined in the appended claims, rather than in the specific description preceding them. All embodiments that fall within the meaning and range of equivalency of the claims are therefore intended to be embraced by the claims.











BRIEF DESCRIPTION OF DRAWINGS





FIG. 1

is a plan view with parts broken away showing an ablation catheter system of the present invention;





FIG. 2

is a greatly magnified broken-away plan view of a tip portion of an electrode in accordance with the invention;





FIG. 3

is a view of the enlarged fragmentary tip portion, shown in

FIG. 2

, with an electrode shown in the expanded condition;





FIG. 4

is a yet, more greatly enlarged fragmentary view of the tip portion of an electrode of the present invention with parts shown in cross-section for clarity.





FIG. 5

shows a diagrammatic view of the cardiac ablation system shown in

FIG. 3

coupled to a source of radio frequency electromagnetic energy and an indifferent electrode for electrically heating and ablating myocardial tissue; and





FIG. 6

is a view of the enlarged fragmentary tip portion, as shown in

FIG. 3

, with the conductive coating applied in a pattern.











DETAILED DESCRIPTION





FIG. 1

shows a system


10


for performing ablation on cardiac tissue that embodies the features of the invention.




The system


10


also includes a steerable catheter


14


carrying an expandable energy emitting body


16


.




In

FIG. 1

, the catheter


14


includes a handle


20


, a guide tube


22


, and a distal tip


24


. In this embodiment, the tip


24


carries the energy emitting body


16


(see FIG.


2


).




As

FIG. 2

shows, a series of ring electrodes


25


encircle the guide tube


22


close to the energy emitting body


16


. These ring electrodes


25


can be used for sensing electrograms to locate the region that is to be ablated.




The handle


20


encloses a steering mechanism


26


for the catheter tip


24


. A cable


28


extending from the rear of the handle


20


has plugs


29


which connect the catheter


14


to a source of ablation energy. The ablation energy is conveyed through the wires


12


to the body


16


for creating lesions in tissue within the heart.




While the type of ablation energy used can vary, in the illustrated embodiment (see FIG.


5


), radio frequency (RF) electromagnetic energy is used. The energy source therefore comprises a radio frequency


50


. While the RF


50


can be constructed in various ways, the RF generator preferably delivers up to about 150 watts of power at a frequency of about 350 to 700 kHz, and most preferably, about 500 kHz.




Left and right steering wires (not shown) extend through the guide tube


22


to interconnect the steering mechanism


26


with the distal tip


24


. The steering mechanism


26


includes a steering lever


15


.




Various steering mechanisms can be used, for example, the type shown in U.S. Pat. No. 5,195,968.




As

FIG. 1

shows, rotation of the steering lever


15


to the left pulls on the left steering wire, causing the tip


24


to bend to the left. Rotation of the steering lever


15


to the right pulls on the right steering wire, causing the tip


24


to bend to the right.




As

FIG. 1

also shows, the energy emitting body


16


moves along with the tip


24


from left and right as the steering lever


15


is manipulated.




In use, a physician holds the catheter handle


20


and introduces the catheter


14


through a main vein or artery (typically the femoral) into the interior region of the heart that is to be treated. The physician then further steers the distal tip of the catheter


14


by means of the steering lever


15


, to place the body


16


into contact with the tissue within the heart that is targeted for ablation.




The body


16


has a hollow interior. The guide tube


22


includes an interior lumen


27


(see

FIG. 2

) that communicates with the hollow interior of the body


16


.




The catheter assembly


10


includes an injection port


18


for injection of a fluid medium into the lumen


27


. The fluid caused the body


16


to expand or inflate from its normal, low profile condition (as

FIG. 2

shows) to an enlarged operating condition (as

FIG. 3

shows).




The inflating fluid medium can vary. Preferably, it comprises a liquid like as water, saline solution, or other biocompatible fluid.




Alternately the inflating fluid medium can comprise a gaseous medium such as carbon dioxide or air.




Regardless of the type of fluid medium, the inflation preferably occurs under relatively low pressures of up to 30 psi. The pressure used depends upon the desired rate of inflation, the strength and material used for the body


16


, and the degree of flexibility required (i.e., high pressure leads to a harder, less flexible body


16


.




After reaching its desired inflated condition, the physician directs ablation energy through wires


12


into the body


16


. The body emits the ablation energy to heats the tissue. The tissue is thermally destroyed, forming a lesion.




The body


16


can be variously constructed. In the illustrated and preferred embodiment, the body


16


is made of a thermoplastic polymeric material of a pliant nature, like polyethylene. The body


16


is formed by either a free-blown process or a mold process.




The body


16


includes an energy emitting coating applied upon its exterior surface. In the illustrated embodiment, where the body


16


emits RF ablation energy, the coating comprises an electrically conducting material, like platinum or gold.




Coating of the body


16


may be accomplished by conventional painting or sputter coating techniques. For example, gold can be sputtered onto the exterior surface of the body


16


. Alternatively, a two phase sputter coating process may be employed in which an initial layer of titanium is applied followed by an outer coating of gold.




The coating process may also use an ion beam assisted deposition (IBAD) process. This process implants the conductive material into the polymer of the body


16


.




The wires


12


conduct ablating energy to the coating on the body


16


.




The body


16


shown in

FIGS. 2

,


3


and


5


is operated in a unipolar ablation mode. The energy transmitted by the body


16


flows through myocardial tissue to an external indifferent electrode


52


on the patient (see FIG.


5


), which is typically an epidermal patch.




In the illustrated and preferred embodiment, the conductive coating covers the entire exposed area of the body


16


. In this case, the body


16


, when inflated, functions as a single ablation electrode.




Alternatively, the conductive coating can be applied in a defined portion


54


(such as one third or one half) of the circumference of the body


16


(as shown in FIG.


6


), or any variety of patterns that may enhance the ablation performance and/or optimize the ablation procedure.




Additionally, the coated, inflatable body


16


can serve to carry electrical signals from the heart tissue along wires


12


through cable


28


and plugs


29


for recording of electrogram potentials by recording equipment.




The inflatable body


16


can be attached to the distal tip


24


of guide tube


22


in various ways.




In the illustrated embodiment, as best seen in

FIG. 4

, the distal end of guide tube


22


is adhered over a high resistivity layer


30


of a polymer, such as an epoxy resin. The layer


30


, in turn, overlies a conductive ring


32


.




The distal end of the signal wire


12


is attached to conductive ring


32


, which is conductively connected to the outer electrically conductive coating


34


on the outer surface of tip


16


, preferably using a highly conductive material, like epoxy resin.




In this arrangement, the inflation lumen


27


forms a fluid pressure transmitting conduit which communicates with the interior of body


16


. The lumen


27


extends from the injection port


18


through the bore


25


of the guide tube


22


to the distal tip


24


.




The physician has the option to maneuver the distal catheter tip


24


toward the desired endocardial location. The physician may inflate the body


16


whenever the physiology and safety of the patient allows, either within the heart or while in transit toward the heart, by conducting positive fluid pressure through the lumen


27


to the inflatable body


16


.




The positive fluid pressure causes the body


16


to expand or inflate. The inflating body


16


deploys outward, assuming a prescribed three dimension shape. The shape can vary, depending upon the premolded configuration of the body


16


. In the illustrated embodiment, the body


16


assumes a somewhat spherical shape when inflated.




The inflation is conducted to the extent that the body


16


is filled and expanded, but not stretched. The electrical conductivity of the coating on the body


16


is thus not disturbed or impaired.




Due to its pliant nature, the body


16


, when inflated, naturally conforms to the topography of the endocardial surface next to it.




Release of the positive fluid pressure and the application of negative pressure through the supply conduit will drain fluid from the body


16


. The body


16


collapses back into a deflated condition and, depending on the specific catheter design, may be retracted back into the catheter.




Alternatively, a movable sheath controlled by a retraction mechanism can be used to selectively enclose the body


16


before and after use, during insertion into and retraction from the body. The retraction mechanism is retracted to free the body


16


for inflation and use.




The body


16


can be carried on existing catheter assemblies. When in its normal, low profile condition, shown in

FIG. 1

, the body


16


maintains a standard 6, 7, or 8 French size. When in its inflated condition, shown in

FIG. 2

, the same body


16


has an significantly enlarged dimension ranging from approximately 7 mm to 12 mm.




In the illustrated and preferred embodiment (see FIG.


4


), the system


10


includes monitoring means


42


for sensing the temperature.




While the monitoring means


42


may be variously constructed, in the illustrated embodiment, it temperature sensing means


44


associated with the body


16


. The means


44


includes a small bead thermistor with associated lead wires


46


that pass through the interior of the body


16


. A sheath


48


provides a protective conduit for the lead wires


46


. The wires


46


extend back to the handle


20


for electrical connection to cable


28


.




Preferably, the system


10


also includes control means (not shown) for the energy power supply that is responsive to the sensed temperature for performing generator control functions.



Claims
  • 1. A tissue ablating catheter, comprising:an elongated guide member having a cross sectional dimension; a body carried by the guide member having an exterior surface with a normal cross sectional dimension no greater than the cross sectional dimension of the guide member and inflatable from its normal cross sectional dimension to a second cross sectional dimension greater than the cross sectional dimension of the guide member; and an electrically conductive coating on the exterior surface of the body to transmit RF ablating energy from the body sufficient to cause permanent, irreversible thermal damage to body tissue.
  • 2. The catheter of claim 1, further including a temperature sensing device associated with the body.
  • 3. The catheter of claim 1, wherein the body is formed of a polymer material.
  • 4. The catheter of claim 1, further including an element to deflect the guide member to position the body.
  • 5. The catheter of claim 1, wherein the guide member includes a layer of high resistivity material sandwiched between the guide member and the electrically conductive coating to attach the body to the guide member.
  • 6. The catheter of claim 1, wherein the coating covers the entire body.
  • 7. The catheter of claim 1, wherein the coating comprises a pattern applied to the body.
  • 8. The catheter of claim 1, wherein the catheter is a cardiac ablating catheter and the electrically conductive coating carries electrical signals from myocardial tissue to map electrical activity in myocardial tissue.
  • 9. A cardiac ablating catheter, comprising:an elongated guide member having a cross sectional dimension; a body carried by the guide member having an exterior surface with a normal cross sectional dimension no greater than the cross sectional dimension of the guide member and inflatable from its normal cross sectional dimension to a second cross sectional dimension greater than the cross sectional dimension of the guide member; and an electrically conductive coating on the exterior surface of the body to carry electrical signals from myocardial tissue to map electrical activity in myocardial tissue and to transmit RF ablating energy from the body sufficient to cause permanent, irreversible thermal damage to myocardial tissue.
  • 10. A tissue ablating catheter, comprising:an elongated guide member having a cross sectional dimension; a body carried by the guide member having an exterior surface with a normal cross sectional dimension no greater than the cross sectional dimension of the guide member and inflatable from its normal cross sectional dimension to a second cross sectional dimension greater than the cross sectional dimension of the guide member; an electrically conductive coating on the exterior surface of the body to transmit RF ablating energy from the body sufficient to cause permanent, irreversible thermal damage to body tissue; a layer of electrically conductive material overlying a portion of the electrically conductive coating; and a wire electrically connected to the electrically conductive layer to conduct ablating energy to the electrically conductive coating.
  • 11. The catheter of claim 10, wherein the guide member includes a layer of high resistivity material sandwiched between the guide member and the electrically conductive coating to attach the body to the guide member.
RELATED APPLICATION

This application is a continuation of U.S. application Ser. No. 08/099,994, filed on Jul. 30, 1993, now U.S. Pat. No. 6,086,581, which is a continuation-in-part of U.S. application Ser. No. 07/951,728, filed Sep. 25, 1992, now U.S. Pat. No. 5,471,982, and entitled “Cardiac Mapping and Ablation Systems.”

US Referenced Citations (59)
Number Name Date Kind
3326207 Egan Jun 1967 A
3435826 Fogarty Apr 1969 A
3448739 Stark et al. Jun 1969 A
4444195 Gold Apr 1984 A
4522212 Gelinas et al. Jun 1985 A
4573473 Hess Mar 1986 A
4628937 Hess et al. Dec 1986 A
4630611 King Dec 1986 A
4641649 Walinsky et al. Feb 1987 A
4649924 Taccardi Mar 1987 A
4660571 Hess et al. Apr 1987 A
4662383 Sogawa et al. May 1987 A
4664120 Hess May 1987 A
4676258 Inokuchi et al. Jun 1987 A
4681117 Brodman et al. Jul 1987 A
4690148 Hess Sep 1987 A
4690155 Hess Sep 1987 A
4699147 Chilson et al. Oct 1987 A
4784133 Mackin Nov 1988 A
4862887 Weber et al. Sep 1989 A
4882777 Narula Nov 1989 A
4890623 Cook et al. Jan 1990 A
4891102 Astrinsky et al. Jan 1990 A
4928695 Goldman et al. May 1990 A
4940064 Desai et al. Jul 1990 A
4944088 Doan et al. Jul 1990 A
4945912 Langberg Aug 1990 A
4952357 Euteneuer Aug 1990 A
4955377 Lennox et al. Sep 1990 A
4974162 Siegel et al. Nov 1990 A
4976710 Mackin Dec 1990 A
4976711 Parins et al. Dec 1990 A
4979510 Franz et al. Dec 1990 A
4979948 Geddes et al. Dec 1990 A
5003991 Takayama et al. Apr 1991 A
5006119 Acker et al. Apr 1991 A
5025786 Siegel Jun 1991 A
5029585 Lieber et al. Jul 1991 A
5041973 Lebron et al. Aug 1991 A
5045056 Behl Sep 1991 A
5056517 Fenici Oct 1991 A
5084044 Quint Jan 1992 A
5114423 Kasprzyk et al. May 1992 A
5150717 Rosen et al. Sep 1992 A
5156151 Imran Oct 1992 A
5195968 Lundquist Mar 1993 A
5228442 Imran Jul 1993 A
5255678 Deslauriers et al. Oct 1993 A
5255679 Imran Oct 1993 A
5263493 Avitall Nov 1993 A
5277201 Stern Jan 1994 A
5282845 Bush et al. Feb 1994 A
5311866 Kagan et al. May 1994 A
5324968 Imran Jun 1994 A
5345936 Pomeranz et al. Sep 1994 A
5575772 Lennox Nov 1996 A
5588432 Crowley Dec 1996 A
5860974 Abele Jan 1999 A
6086581 Reynolds et al. Jul 2000 A
Foreign Referenced Citations (6)
Number Date Country
35116830 Nov 1986 DE
2077596 Dec 1981 GB
2163055 Feb 1986 GB
1220673 Mar 1986 SU
8906148 Jul 1989 WO
WO9501751 Jan 1995 WO
Non-Patent Literature Citations (1)
Entry
Schaudinischky et al; “The Shape Conforming Electrode”, Med. & Biol. Eng., vol. 7, pp. 341-343. 1969.
Continuations (1)
Number Date Country
Parent 08/099994 Jul 1993 US
Child 09/533023 US
Continuation in Parts (1)
Number Date Country
Parent 07/951728 Sep 1992 US
Child 08/099994 US